Document is current
Any future updates will be listed below
-
Authors
Vandenbark, Arthur A.
Meza-Romero, Roberto
Benedek, Gil
Offner, Halina
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R42AI122574)
National Institute of Neurological Disorders and Stroke (R01NS080890)
U.S. Department of Veterans Affairs (2I01 BX000226, 1IK6BX004209)
- License Information
-
More Information
Article History
Received: 17 December 2018
Accepted: 27 December 2018
First Online: 23 January 2019
Ethics approval and consent to participate
: Not applicable to this review specifically.
: Not applicable to this review specifically.
: Drs. Vandenbark, Offner, Benedek, Meza-Romero, and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by the OHSU and VA Portland Health Care System Conflict of Interest in Research Committees.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
